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Abstract. 
 
Endoplasmic reticulum (ER) proteins main-
tain their residency by static retention, dynamic re-
trieval, or a combination of the two. Tail-anchored pro-
teins that contain a cytosolic domain associated with 
the lipid bilayer via a hydrophobic stretch close to the 
COOH terminus are sorted within the secretory path-
way by largely unknown mechanisms. Here, we have in-
vestigated the mode of insertion in the bilayer and the 
intracellular trafﬁcking of cytochrome b(5) (b[5]), 
 
taken as a model for ER-resident tail-anchored proteins. 
We ﬁrst demonstrated that b(5) can acquire a trans-
membrane topology posttranslationally, and then used 
two tagged versions of b(5), N-glyc and O-glyc b(5), 
containing potential N- and O-glycosylation sites, re-
spectively, at the COOH-terminal lumenal extremity, to 
discriminate between retention and retrieval mecha-
nisms. Whereas the N-linked oligosaccharide provided 
no evidence for retrieval from a downstream compart-
ment, a more stringent assay based on carbohydrate ac-
quisition by O-glyc b(5) showed that b(5) gains access 
to enzymes catalyzing the ﬁrst steps of O-glycosylation. 
These results suggest that b(5) slowly recycles between 
the ER and the 
 
cis
 
-Golgi complex and that dynamic re-
 
trieval as well as retention are involved in sorting of tail-
anchored proteins.
Key words: cell compartmentation • endoplasmic 
reticulum • glycosylation • Golgi apparatus • mem-
brane proteins
 
Introduction
 
Notwithstanding the intense membrane traffic taking place
within eukaryotic cells, subcellular compartments main-
tain their molecular identity with remarkable accuracy.
Within the secretory pathway, proteins that reside in a
given compartment must avoid being relocated to neigh-
boring compartments in the face of ongoing transport.
Two different mechanisms, static retention and dynamic
retrieval, can, in principle, ensure that each compartment
keeps its cohort of resident proteins. Retained proteins are
thought to be simply excluded from transport out of their
compartment of residence, whereas retrieved proteins do
escape to a downstream organelle from which they are re-
cycled by retrograde transport (Pelham and Munro, 1993).
Consistent with its diverse functions, the membrane of
the ER has a complex molecular composition, and many
studies have been devoted to the mechanisms through
which it keeps its numerous resident polypeptides from
following transported proteins down the secretory path-
way. These studies have shown that both retrieval via coat
protein I–coated vesicles and retention are operative in
determining residence of ER membrane proteins (for re-
view see Teasdale and Jackson, 1996). Of the two mecha-
nisms, the former is better understood, and retrieval sig-
nals have been identified in the cytosolic tails of type I and
type II ER resident membrane proteins (Cosson and Le-
tourneur, 1994; Teasdale and Jackson, 1996; Cosson et al.,
1998). In addition, a number of membrane proteins are
retrieved by interaction of their transmembrane domains
(TMDs)
 
1
 
 with a recently identified receptor, rer1p (Sato et
al., 1996, 1997). Less information is available on static re-
tention. Although it could be argued that retention is ef-
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fected simply by the absence of positive signals required
for efficient recruitment of cargo protein into transport
vesicles (Springer et al., 1999), it is likely that specific re-
tention signals or features are also necessary to prevent ac-
cess of retained proteins into budding vesicles (Sonnichsen
et al., 1994).
Although there is evidence that both retrieval and re-
tention operate at the ER–Golgi complex boundary, an
important question that is still largely unresolved are the
relative roles played by these two mechanisms in deter-
mining the residency of ER membrane proteins. Post-
translational modifications are generally used to follow in-
tracellular trafficking between the ER and the Golgi.
However, many ER membrane proteins do not have
consensus sites for such modifications and are thus diffi-
cult to study. For instance, membrane proteins with the
so-called tail-anchored (TA) topology, consisting of an
NH
 
2
 
-terminal active cytosolic domain and a hydrophobic
membrane-anchoring region close to the COOH termi-
nus, essentially lack a lumenal domain (for reviews see
Borgese et al., 1993; Kutay et al., 1993). Many ER en-
zymes whose catalytic activity is at the cytosolic side of the
membrane have a TA topology, e.g., cytochrome b(5) (b[5]),
heme oxygenase, aldehyde dehydrogenase, and ubiquitin
conjugating enzyme 6, and unraveling their sorting mecha-
nisms would make an important contribution to our un-
derstanding of the genesis and maintenance of the molecu-
lar identity of the ER. In our laboratory we have been
using b(5) as a model to study the targeting and sorting of
ER-resident TA proteins. b(5) is an 
 
z
 
15,000-
 
M
 
r
 
 protein
with an NH
 
2
 
-terminal, globular cytosolic heme-binding
domain, a short connecting region, and a hydrophobic an-
choring domain followed by seven polar residues at the ex-
treme COOH terminus (for review see Borgese et al.,
1993). Since ER-resident TA enzymes generally have
short hydrophobic anchoring domains (14–18 residues),
we investigated a possible role of the length of the hydro-
phobic domain in sorting and demonstrated that a short
anchoring domain is required to keep b(5) from escaping
from the ER and from travelling down the secretory path-
way to the cell surface (Pedrazzini et al., 1996). A similar
observation was subsequently made on other ER-resident
TA proteins (Rayner and Pelham, 1997; Yang et al., 1997),
establishing the generality of tail length–dependent sort-
ing. However, an open question remained as to whether
the short hydrophobic domain effects ER residence of TA
proteins by a static retention or by a dynamic retrieval
mechanism. In this study, we have investigated this ques-
tion. Using tagged versions of b(5) with N- or O-glycosyla-
tion sites attached at the COOH terminus, we show that
b(5) gains access to enzymes catalyzing the first steps of
O-glycosylation, suggesting that it slowly recycles between
the ER and the 
 
cis
 
-Golgi.
 
Materials and Methods 
 
Plasmid Constructions
 
A cDNA coding for the rabbit ER form of b(5) (Giordano and Steggles,
1992) and subcloned into pGEM 4 and into the mammalian expression
vector pCB6 (Brewer and Roth, 1991), has been described in previous
work (Pedrazzini et al., 1996). We refer to the protein expressed from this
plasmid as wild-type (wt) b(5).
 
To facilitate addition of sequence tags at the COOH terminus of b(5),
we introduced a unique Age1 site at the border between the hydrophobic
domain and the extreme COOH-terminal polar region, which did not alter
the encoded amino acid sequence, and Xba1 and Hind3 sites immediately
after the stop codon. The three restriction sites were introduced by substi-
tuting a 3
 
9
 
 terminal Aat2-Hind3 620-bp fragment of wt b(5) in pGEM4
(the Aat2 site at position 335 and the Hind3 site in the polylinker) with a
214-bp, PCR-generated fragment. The resulting plasmid (pGb[5]AX) was
used to construct the N-glyc b(5) and O-glyc b(5) mutants, which con-
tained, close to their COOH termini, potential N- and O-glycosylation
sites, respectively. The 25-bp Age1-Xba1 fragment of pGb(5)AX was re-
placed with an 89-bp duplex or 86-bp duplex obtained by annealing two
complementary synthetic oligonucleotides coding for the sequences illus-
trated in Fig. 2 A. The constructs were checked by sequencing and then
subcloned into the Kpn1-Hind3 sites of pCB6 with a modified polylinker
(De Silvestris et al., 1995).
 
Cell Culture and Transfection
 
Most of the experiments in this study were conducted on transiently trans-
fected CV1 cells that were cultured and transfected with the Ca
 
2
 
1
 
PO
 
4
 
method as described previously (De Silvestris et al., 1995). The efficiency
of transfection was usually monitored by cotransfecting with green fluo-
rescent protein (Clontech). For the fractionation experiment (see Fig. 10),
transfection was carried out with lipofectamine (GIBCO BRL) with 0.03 
 
m
 
g
of b(5) cDNA/cm
 
2
 
 of culture dish surface. Cells were used for immuno-
fluorescence or biochemical experiments within 24 h after transfection.
In one experiment (see Fig. 1), an MDCK line stably expressing wt b(5)
was used. MDCK cells were cultured and transfected as described previ-
ously (Borgese et al., 1996). Several b(5)-expressing clones were obtained;
however, the expression was completely lost after only a few passages
in culture, so that further experiments with these clones could not be car-
ried out.
For the experiment shown in Fig. 6 B we used CHO-15B cells grown in
a 5% CO
 
2
 
 incubator in MEM with Earle’s salts 
 
a
 
-modification, supple-
mented with 7.5% FCS, 2 mM glutamine, and antibiotics. These cells were
transfected with the lipofectin (GIBCO BRL), using 0.2 
 
m
 
g of plasmid/
cm
 
2 
 
of culture dish surface.
 
Antibodies
 
The following antibodies (Abs) were produced in our laboratory: (a) af-
finity-purified polyclonal Abs against b(5) raised in rabbits in our labora-
tory (Borgese and Meldolesi, 1976; De Silvestris et al., 1995); (b) an af-
finity-purified polyclonal Ab directed against the 10 COOH-terminal
residues of b(5). 2.4 mg of the peptide (LMYRLYMADD) was conju-
gated to 3 mg of chicken ovalbumin with succinimidyl 4-[
 
N
 
-maleimido-
methyl]-cyclohexane-1-carboxylate (Pierce) and used to immunize a rab-
bit. In addition, the following Abs were generously donated by the
indicated investigators: a monoclonal anti-b(5) mAb from Dr. S. Park (In-
dustrial Health Research Institute, Inchon, Korea) (Park et al., 1992); an
antipeptide polyclonal antiserum against the 10 COOH-terminal amino
acids of ERGIC 53 (QQEAAAKKFF) from Dr. Stefano Bonatti (Univer-
sity of Naples, Naples, Italy); polyclonal Abs against ribophorin I from Dr.
Giovanni Migliaccio (Istituto di Ricerche di Biologia Molecolare, Pome-
zia, Italy) (Nicchitta et al., 1991) and Dr. Gert Kreibich (New York Uni-
versity School of Medicine, New York, NY) (Yu et al., 1990); an anti–
 
b
 
tubulin mAb (DM1
 
a
 
) from Dr. Mark Kirschner (Harvard Medical
School, Boston, MA); a mAb against the NH
 
2
 
-terminal peptide of bovine
opsin (R2-15) from Dr. Paul Hargrave (University of Florida, Gainesville,
FL) (Adamus et al., 1991); an antigiantin polyclonal serum from Dr. M.
Renz (Institute of Immunology and Molecular Genetics, Karlsruhe, Ger-
many) (Seelig et al., 1994). Anti–protein disulfide isomerase (PDI) and
anti-GS28 mAbs were from StressGen Biotechnologies.
 
Immunofluorescence
 
Paraformaldehyde-fixed cells were permeabilized with Triton X-100 and
processed for immunofluorescence as described previously (De Silvestris
et al., 1995). In some experiments, permeabilization of the plasma mem-
brane was carried out with streptolysin O (SLO), obtained from Dr. S.
Bhakdi (Johannes-Gutenberg Universität, Mainz, Germany) (Bhakdi et
al., 1993). Cells grown on coverslips were incubated with a buffer contain-
ing 115 mM K
 
1
 
acetate, 25 mM Hepes-KOH, pH 7.0, 2.5 mM MgCl
 
2
 
, 0.2
mM CaCl
 
2
 
, 1 mM EGTA, 12 mM glucose, 5–30 U/ml SLO for 10 min at 
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4
 
8
 
C. After removal of excess SLO, incubation was continued in the same
buffer lacking SLO at 37
 
8
 
C for 30 min. Cells were observed under a Zeiss
Axioplan microscope equipped for epifluorescence or with a Bio-Rad
MRC 1024 ES laser confocal microscope.
 
Velocity Sucrose Gradient Centrifugation
 
CV1 cells transfected with wt b(5) in a 10-cm petri dish were washed free
of medium with PBS, detached with a rubber policeman, sedimented, and
resuspended in 200 
 
m
 
l of PBS and lysed for 10 min at 0
 
8
 
C with an equal
volume of 2% Triton X-100, 40 mM NaCl, 50 mM Tris-Cl, pH 7.4, and
protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 1 
 
m
 
g/ml leupep-
tin, 1.4 
 
m
 
g/ml pepstatin, 2 
 
m
 
g/ml chymostatin) for 10 min on ice. A
cleared lysate was obtained after centrifugation at 700 
 
g
 
 for 10 min. The
cleared lysate or a fraction of rat liver microsomes (1.3 mg of protein) sol-
ubilized under the same conditions as the cultured cells was loaded on top
of a 12-ml 5–20% linear sucrose gradient containing 20 mM NaCl, 25 mM
Tris-Cl, pH 7.4, 0.2% Triton X-100, in tubes of the SW40 rotor (Beckman
Instruments, Inc.), and centrifuged at 39,000 rpm at 4
 
8
 
C for 16 h. Colored
markers for sedimentation rates (cytochrome c and catalase) were run on
a separate gradient centrifuged in parallel. 15 fractions were collected
from the top with an Auto Densiflow probe (Buchler Instruments) and
subjected to precipitation with TCA in the presence of 80 
 
m
 
g of cytochrome
c as carrier. The precipitated proteins were analyzed by SDS-PAGE fol-
lowed by Western blotting.
 
In Vitro Transcription and Translation
 
N-glyc and O-glyc b(5) in pGEM4 and a cDNA coding for the plant pro-
tein phaseolin cloned in pSP64T were transcribed from the SP6 promoter,
and the resulting synthetic mRNA was translated for 1 h at 32
 
8
 
C in 10 or
20 
 
m
 
l of rabbit reticulocyte lysate (Promega Corp.) as described previ-
ously (Ceriotti et al., 1991), in the presence or absence of 1 
 
m
 
l of dog pan-
creas microsomes (Promega Corp.). In some samples, microsomes were
added posttranslationally. In this case, the translation, carried out in the
absence of microsomes, was stopped by addition of cycloheximide (CHX)
(30 
 
m
 
g/ml), and elimination of ribosomes by centrifugation at 55,000 rpm
for 1 h at 4
 
8
 
C in the Beckman TLA 100.3 rotor. The ribosome-free super-
natants were then incubated for a further hour at 32
 
8
 
C in the presence of
microsomes.
 
Metabolic Labeling Experiments
 
Metabolic labeling was carried out on CV1 or CHO15B cells, plated on
10-cm petri dishes, and transfected with b(5) or tagged versions thereof
the day before exposure to the radioactive precursor. Labeling with 0.1–
0.2 mCi/ml [
 
35
 
S]Met/Cys (Promix; Amersham Pharmacia Biotech) was
carried out as described previously (Borgese et al., 1996). For labeling
with high specific activity [
 
3
 
H]glucosamine (GlcNH
 
2
 
) or galactose (NEN
Life Science Products or American Radiolabeled Chemicals, Inc.), cells
were incubated for 1.5 h in MEM with Earle’s salts containing glucose
at reduced concentration (0.1 g/l) and 3% dialyzed FCS, before addition
of the concentrated radioactive sugar to a final concentration of 0.3–0.6
mCi/ml. The length of the incubations, and the concentrations of added
drugs (brefeldin A [BFA], okadaic acid [OKA], CHX; Sigma Chemical
Co.) are specified in the figure legends.
 
Immunoprecipitation
 
Metabolically labeled cells were collected in PBS, lysed for 10 min at 0
 
8
 
C
with an equal volume of 200 mM NaCl, 50 mM Tris-Cl, pH 7.4, 20 mM
EDTA, 4% Triton X-100, and protease inhibitors. After clearing by cen-
trifugation (1,000 
 
g
 
 for 10 min), the lysates were analyzed for incorpora-
tion of the radioactive precursor and protein content. Aliquots of the ly-
sates, containing equal amounts of incorporated radioactivity or equal
amounts of protein, were precleared by incubation with protein A– or
protein G–Sephrose beads in the presence of 0.2% gelatin, then incubated
with anti-b(5) polyclonal Abs or antiopsin mAbs. The immune complexes
were harvested with protein A– or protein G–Sepharose beads, in some
cases treated with endoglycosidases, and finally analyzed by SDS-PAGE
fluorography.
 
Cell Fractionation
 
Cell fractionation was carried out on cells plated on eight 10-cm petri
dishes transfected with O-glyc b(5) and metabolically labeled with
[
 
3
 
H]GlcNH
 
2
 
. All operations
 
 
 
were carried out at 4
 
8
 
C. Cells were washed
free of medium and detached with a rubber policeman. After collection by
centrifugation, they were washed with homogenization solution (0.25 M
sucrose, 0.5 mM EDTA, 0.5 mM EGTA, 20 mM Tris-Cl, pH 7.5, and pro-
tease inhibitors), resuspended in 1 ml of the same solution, and ruptured
by eight passages through a cell cracker with a 0.0009-inch clearance.
After elimination of nuclei by centrifugation (700 
 
g 
 
for
 
 
 
10 min), the post-
nuclear supernatant (PNS) was brought to 27% wt/vol Optiprep (Ny-
comed), 20 mM tricine/NaOH, pH 7.8, 1.3% sucrose, and 1 mM EDTA,
and layered under a linear 9.5-ml 8–22% isosmotic Optiprep gradient with
the same ions as above. The gradients were topped with 0.3 ml of 8% su-
crose plus
 
 
 
ions, and centrifuged for 2 h at 28,000 rpm at 4
 
8
 
C in a Beckman
SW41 rotor. Fractions were collected and equal aliquots were subjected to
immunoprecipitation followed by SDS-PAGE fluorography or to West-
ern blot analysis.
 
Biochemical Assays
 
Most of the techniques used in this study (SDS-PAGE, Western blotting,
NADPH–cytochrome c enzyme assay) are described in previous publica-
tions (Borgese and Pietrini, 1986; Borgese et al., 1996). Autoradiograms
and fluorograms were scanned and band intensities determined using the
NIH Image software.
For endoglycosidase (Endo) H treatment, immune complexes were de-
tached from protein G–Sepharose beads by incubation for 3 min at 100
 
8
 
C
in an equal volume of 40 mM Tris-Cl, pH 6.8, 4% SDS, 2% 
 
b
 
-mercapto-
ethanol, and 17% glycerol. After sedimentation of the beads, the superna-
tant was supplemented with five volumes of 0.1 M Na
 
1
 
 citrate buffer, pH
5.5, 0.6 
 
m
 
l of a 100-mg/ml solution of BSA and protease inhibitors, and
then incubated overnight at 37
 
8
 
C with or without 10 mU of Endo H (Boeh-
ringer Mannheim). 5–10 
 
m
 
l of in vitro translation mix was similarly dena-
tured and digested. For Endo D treatment, samples were denatured as for
Endo H digestions, but the SDS-containing supernatants were diluted
with five volumes of 0.25 M Na
 
1
 
phosphate, pH 7.2, 10 mM EDTA plus
BSA, and protease inhibitors. Digestion was carried out overnight with 3
mU of Endo D (Boehringer Mannheim).
 
Results
 
Transmembrane Topology of b(5)
 
To plan a strategy for the investigation of the mechanism
of residence of b(5) in the ER, it was first necessary to de-
fine the topology of the hydrophobic membrane-anchor-
ing domain. Although b(5) is perhaps the first TA protein
to have been characterized, there has been controversy as
to whether it adopts a transmembrane disposition or
whether it loops back into the cytosol. We investigated this
problem with two different approaches as described below.
In the first approach, we used an Ab raised against the
COOH terminus of b(5) (see Materials and Methods) to
probe the accessibility of the COOH-terminal polar pep-
tide by immunofluorescence in an MDCK cell line stably
expressing b(5). Although this cell line originated from a
single clone, only 
 
z
 
30% of the cells expressed detectable
levels of b(5) at any one time. Cells were treated either
with SLO to selectively permeabilize the plasma mem-
brane (Bhakdi et al., 1993), or with Triton X-100 after fixa-
tion to permeabilize intracellular membranes. As shown in
Fig. 1, when the cells were permeabilized only with SLO,
the cytosol became accessible to IgG, as demonstrated by
the staining with antitubulin mAbs, which were equally ef-
fective with or without Triton X-100 permeabilization
(compare Fig. 1, B and D). In contrast, the ER lumen of
SLO-permeabilized cells was poorly accessible, as demon-
strated by the low (probably nonspecific) staining ob-
tained with mAbs against the lumenal protein PDI (com-
pare Fig. 1, F and H). Under this same condition, the 
The Journal of Cell Biology, Volume 148, 2000 902
 
COOH terminus of b(5) was not accessible to Abs (Fig. 1
A), which were, however, capable of binding their epitope
after Triton X-100 treatment (Fig. 1 C). In contrast to the
anti–COOH-terminal peptide Ab, Abs raised against the
catalytic domain of b(5) were able to bind the antigen re-
gardless of the permeabilization protocol (Fig. 1, E and
G). The results illustrated in Fig. 1 are evaluated quantita-
tively in Table I, and are consistent with a lumenal loca-
tion of the COOH-terminal polar peptide of b(5).
In the second approach, the COOH terminus of b(5)
was extended with a sequence containing a consensus for
N-glycosylation, as reporter for translocation into the ER
lumen. The appended sequence (Fig. 2 A) was derived
from the NH
 
2
 
 terminus of bovine opsin. The resulting con-
struct, N-glyc b(5), was translated in vitro under different
conditions. As shown in the upper panel of Fig. 2 B, lane 1,
when N-glyc b(5) was translated in the presence of dog
pancreas microsomes, two bands were obtained, of which
one comigrated with the product obtained in the absence
of membranes (lanes 3 and 4), and the other, indicated by
the arrow, had a slower mobility and was Endo H–sensi-
tive (lane 2), demonstrating that N-glyc b(5)’s COOH ter-
minus is translocated across the membrane to become
glycosylated. More importantly, if N-glyc b(5) was first
Figure 1. The COOH-termi-
nal polar peptide of b(5) is in-
accessible to Ab if the ER
membrane is not permeabi-
lized. MDCK cells overex-
pressing wt b(5) were perme-
abilized with SLO (5 U/ml;
see Materials and Methods),
then fixed and processed for
immunofluorescence in the
presence (C, D, G, and H) or
absence (A, B, E, and F) of
Triton X-100. Cells were
doubly labeled with the fol-
lowing pairs of Abs: poly-
clonal Ab raised against the
10 COOH-terminal amino
acids of b(5) (A and C) and
antitubulin mAb (B and D);
polyclonal Ab against the
catalytic domain of b(5)
(E and G) and anti-PDI
mAb (F and H). Polyclonal
and monoclonal Abs were
viewed with TRITC- and
FITC-conjugated secondary
Abs, respectively. The pan-
els on the left and right side
of the figure represent the
same fields viewed under the
rhodamine or fluorescein fil-
ters. Fields of cells treated or
not treated with Triton X-100
were photographed and
printed with the same expo-
sures. Bar, 10 mm. 
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translated, and microsomes that were added after transla-
tion were blocked by CHX, and ribosomes were removed
by sedimentation, N-glyc b(5) was still glycosylated with
high efficiency (lanes 5 and 6), demonstrating that the hy-
drophobic domain is capable of translocating downstream
residues posttranslationally. As a control, we analyzed the
behavior of phaseolin, a plant vacuolar glycoprotein that is
translocated across the ER cotranslationally (Ceriotti et
al., 1991). As shown in the lower panel of Fig. 2 B, lane 1,
phaseolin was modified to the mono- and diglycosylated
forms (marked by one and two asterisks, respectively)
when microsomes were present during translation, but re-
mained unglycosylated when membranes were added after
translation (lanes 5 and 6).
 
b(5) Overexpressed in CV1 Cells Is in the ER in a 
Nonaggregated State
 
In mammalian cells, the first station after exit from the ER
is a tubular vesicular compartment, also known as an inter-
mediate compartment (IC) (Bannykh and Balch, 1997).
Some proteins that are kept in the ER by a retrieval mech-
anism can be detected by immunofluorescence in the IC
(Jackson et al., 1993; Martire et al., 1996; Lotti et al., 1999),
and this IC localization can be increased by incubation at
15
 
8
 
C, a temperature that blocks exit from the IC (Jackson
et al., 1993). We investigated whether this was also the
case for b(5) by comparing its intracellular distribution
with that of ERGIC 53, a marker for the IC (Schweizer et al.,
1988), after incubation of transfected CV1 cells at 37 or
15
 
8
 
C. As can be seen in Fig. 3, b(5) could not be detected
in structures enriched in ERGIC 53 either under normal
incubation conditions (Fig. 3, A–C), or after prolonged in-
cubation at 15
 
8
 
C (Fig. 3, D–F). Under the latter condition,
ERGIC 53–containing elements clustered in the Golgi
area (compare Fig. 3, E and B) in agreement with the re-
cent observations of Klumperman et al. (1998). It should
be mentioned that at longer times after transfection (
 
.
 
24 h),
b(5) was often seen to concentrate in large structures that
were positive for ER markers (see Fig. 10). These struc-
tures may be related to the karmellae, which are induced
in yeast cells by overexpression of b(5) (Vergères et al.,
1993). To avoid excessive formation of these structures, all
the experiments described in this paper were initiated
within 24 h after transfection.
 
Table I. Quantitative Analysis of b(5) Immunofluorescence in 
Transfected MDCK Cells Permeabilized with SLO or with
SLO 
 
1
 
 Triton X-100
 
Triton X-100 Antibodies against
Total cells
counted Positive cells
 
Number %
 
1
 
Catalytic domain 303 102 33.7
 
2
 
Catalytic domain 218 77 35.3
 
1
 
COOH-terminal polar peptide 282 71 25.2
 
2
 
COOH-terminal polar peptide 168 0 0
 
MDCK cells expressing b(5) were permeabilized with 5 U/ml SLO and then fixed with
4% paraformaldehyde (see Materials and Methods). Coverslips were processed for
immunofluorescence using primary Abs with the indicated specificities in the absence
or presence of 0.6% Triton X-100. 10 photomicrographs of random fields, each in
phase-contrast and in epifluorescence, were taken with a 40
 
3
 
 magnification lens with
the same exposure for each sample, and total cells as well as positive immunofluorescent
cells were counted.
Figure 2. In vitro translated N-glyc b(5) becomes glycosylated in
the presence of dog pancreas microsomes added either during or
after translation. (A) COOH-terminal sequences of wt b(5) and
of the N-glyc and O-glyc constructs. In all constructs, the hatched
rectangle represents the COOH-terminal part of the membrane-
anchoring domain. The underlined sequence in N-glyc b(5) cor-
responds to the first 19 amino acids of bovine opsin, and is con-
nected to the COOH terminus of b(5) through a Ser and an Arg
residue (italics). An N-glycosylation consensus sequence is
boxed. The underlined sequence of O-glyc b(5), connected to the
COOH terminus of b(5) via the SR sequence (italics), corre-
sponds to residues 36–48 and residue 50 of mature human gly-
cophorin A. The residues in boldface (Y between V48 and T50
and the three COOH-terminal prolines) were included to create an
optimal consensus for O-glycosylation (Yoshida et al., 1997). The
boxed residues are those that are glycosylated in native glyco-
phorin A (Tomita and Marchesi, 1975). (B) N-glyc b(5) (upper
panel) or bean phaseolin (lower panel) synthetic RNAs were
translated for 1 h in the rabbit reticulocyte system in the presence
(lanes 1 and 2; Mbs co) or absence (lanes 3–6) of dog pancreas
microsomes. One sample, which was first incubated in the ab-
sence of microsomes, was then treated with CHX, subjected to
ultracentrifugation to remove ribosomes (see Materials and
Methods), and further incubated for 1 h with microsomes (lanes 5
and 6; Mbs post). At the end of the incubations, samples were di-
vided into two, denatured with SDS, and then incubated over-
night in the presence (lanes 2, 4, and 6) or absence (lanes 1, 3, and
5) of Endo H (see Materials and Methods). The arrow in the up-
per panel indicates the Endo H–sensitive polypeptide (glyco-
sylated N-glyc b[5]) generated when microsomes were present
during or after translation. The single and double asterisks in the
lower panel indicate the mono- and diglycosylated forms of
phaseolin, respectively (Ceriotti et al., 1991), which were gener-
ated only when membranes were present during the translation.
Numbers on the left indicate the position and size (in kD) of Mr
markers. 
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Because a number of ER membrane proteins, including
the ribophorins, are found in rapidly sedimenting aggre-
gates after solubilization of microsomes with nonionic de-
tergents, it is thought that in situ they form an intramem-
branous proteinaceous network, which could also be the
basis for their retention in the ER (Yu et al., 1989). To in-
vestigate whether overexpressed b(5) might belong to
such an aggregate, we analyzed its sedimentation on su-
crose velocity gradients after detergent extraction from
transfected CV1 cells and compared it with that of ribo-
phorin I and of b(5) endogenous to rat liver microsomes.
As can be seen from Fig. 4, under the conditions used, ri-
bophorin I extracted both from rat liver microsomes (Fig.
4 A) and from transfected CV1 cells (Fig. 4 B) formed rap-
idly sedimenting aggregates, in agreement with published
work (Hortsch et al., 1986; Yu et al., 1989). In contrast,
b(5) from rat liver microsomes or transfected CV1 cells
was recovered in the upper fractions of the gradient,
cosedimenting with cytochrome c as expected for the
monomeric form of the protein (
 
M
 
r
 
 
 
z
 
15,000), suggesting
that it exists in a freely diffusible form within the ER of
the transfected cells.
 
Use of Tagged Versions of b(5) to Follow Its 
Intracellular Trafficking
 
To investigate with biochemical methodology whether
Figure 3. Comparison of the
distribution of overexpressed
wt b(5) with that of endoge-
nous ERGIC 53 in trans-
fected CV1 cells incubated at
37 or 158C. Transfected cells
were incubated in DME,
Hepes modification (Sigma
Chemical Co.) in thermo-
stated water baths for 5 h at
378C (A–C) or 158C (D–F),
fixed and permeabilized, and
doubly stained with anti-b(5)
mAbs followed by TRITC-
conjugated anti–mouse IgG
(A and D), and polyclonal
anti–ERGIC 53 followed by
FITC-conjugated anti–rab-
bit IgG (B and E). A single
confocal section is shown for
each incubation condition.
Images of the same field
were acquired separately
with Texas red (A and D)
and fluorescein (B and E) fil-
ters. C and F show the
merged images of the two
acquisitions. Bar, 10 mm.
 
Figure 4.
 
Velocity gradient analysis of b(5) solubilized from rat
liver microsomes or transfected CV1 cells. Rat liver microsomes
(A) or CV1 cells transfected with wt b(5) cDNA were lysed and
loaded onto a 5–20% sucrose gradient containing 0.2% Triton
X-100 and low salt, as described in Materials and Methods. Frac-
tions were analyzed by Western blotting. Ribophorin (R) forms
aggregates which distribute throughout the gradient and sedi-
ment into the pellet, whereas b(5) is found only in the top frac-
tions, cosedimenting with cytochrome c. The vertical large and
small arrowheads in both panels indicate the positions reached
by cytochrome c (
 
M
 
r
 
  
 
z
 
12,300) and catalase (
 
M
 
r
 
  
 
z
 
232,000), re-
spectively. Numbers on the left of the panels indicate the position
and size (in kD) of 
 
M
 
r
 
  markers used in the Western blot analysis. 
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b(5) is retrieved from a downstream compartment, we
used COOH-terminally appended tags to report on the in-
tracellular compartments visited by b(5) during its life-
time. In addition to N-glyc b(5) described above, we con-
structed a mutant with potential O-glycosylation sites at
the COOH terminus (O-glyc b[5]; Fig. 2 A). The sequence
chosen was derived from human glycophorin A (residues
35–48), followed by the sequence YTPPP, in which the
Thr residue is in an optimal consensus for O-glycosylation
(Yoshida et al., 1997).
We first checked by immunofluorescence whether the
added tags altered the intracellular distribution of b(5) in
transiently transfected CV1 cells. As shown in Fig. 5, both
polypeptides had a reticular distribution and a clear local-
ization to the nuclear envelope, indicative of an ER local-
ization. Moreover, like the wt protein, they were not con-
centrated in structures enriched in ERGIC 53, and their
catalytic domain was accessible to Abs restricted to the cy-
tosol, as demonstrated by the good reaction obtained in
cells permeabilized only with SLO.
 
The Majority of N-glyc b(5) Does Not Reach the 
Compartment of Residence of Golgi Mannosidases
I and II
 
To see whether the N-glycan of N-glyc b(5) is modified by
mannosidase II, which is generally localized in the medial
Golgi cisterna (Velasco et al., 1993), we investigated
whether the metabolically labeled protein could acquire
Endo H resistance. Cells were labeled with [
 
35
 
S]Met/Cys
for 2 h, then chased for 6 h, and N-glyc b(5) was immuno-
precipitated and analyzed by SDS-PAGE fluorography.
As shown in Fig. 6 A, lanes 1 and 2, after the 2 h pulse,
most of the in vivo synthesized N-glyc b(5) was glyco-
sylated and Endo H–sensitive; Endo H sensitivity was
completely retained also after 6 h of chase (Fig. 6 A, lanes
3 and 4). Since some N-linked glycans are not accessible to
mannosidase II, even if they do transit through the Golgi,
we checked whether the high mannose oligosaccharide at-
tached to N-glyc b(5) could be modified by mannosidase II
if forced into a common intracellular compartment. When
cells were incubated with BFA to relocate Golgi enzymes
to the ER (Lippincott-Schwartz et al., 1989), a portion of
N-glyc b(5) was converted to a more slowly migrating
Endo H–resistant polypeptide (Fig. 6 A, lanes 5 and 6).
We conclude that under normal conditions N-glyc b(5)
does not reach the compartment of residence of mannosi-
dase II.
An earlier step in N-glycan processing is trimming by
mannosidase I, an event that can be monitored by assess-
ing the acquisition of sensitivity to Endo D. We investi-
gated the Endo D sensitivity of N-glyc b(5) in CHO 15B
cells, which lack N-acetylglucosamine (GlcNac) trans-
ferase I activity, to avoid a possible loss of Endo D sensi-
tivity by further processing in the Golgi. As shown in Fig. 6
B, nearly all of the N-glyc b(5) remained Endo D–resistant
after 6 h of chase (Fig. 6 B, lanes 1 and 2). However, com-
pared with the nondigested sample, a small increase in the
Figure 5. N-glyc and O-glyc
b(5) have a reticular distribu-
tion in transfected cells and
their catalytic domain is ac-
cessible to Abs restricted to
the cytosol. CV1 cells trans-
fected with N-glyc b(5) (A
and B) or O-glyc b(5) (C and
D) cDNA were permeabi-
lized with SLO (30 mg/ml),
and then fixed and doubly
stained with mAbs against
the catalytic domain of b(5)
followed by TRITC-conju-
gated anti–mouse IgG (A and
C), and with polyclonal Abs
against the cytosolic tail of
ERGIC 53 followed by FITC-
conjugated anti–rabbit IgG
(B and D). The figure shows
single confocal sections of
one field for each construct.
The panels on the left and
right side of the figure repre-
sent the same fields acquired
with the Texas red or fluores-
cein filters. Asterisks indi-
cate the nuclei of transfected
cells. Note the clear staining
of the nuclear envelope by
anti-b(5) Abs both in N-glyc
and O-glyc b(5)–transfected
cells, indicative of ER local-
ization. Bar, 10 mm. 
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amount of deglycoyslated polypeptide was visible after
Endo D treatment (Fig. 6 B, arrow), suggesting that a
small proportion of the tagged b(5) may have had access
to mannosidase I. After incubation with BFA, all of the
N-glyc b(5) became Endo D–sensitive (Fig. 6 B, lanes 3
and 4). These results indicate that the vast majority of
N-glyc b(5) molecules do not reach the compartment of
residence of mannosidase I during a 6-h chase.
 
Glycosylation of O-glyc b(5)
 
The results presented in Fig. 6 indicate that N-glyc b(5)
does not recycle through the medial Golgi; however, it was
possible that it reaches an earlier Golgi subcompartment.
To investigate this possibility, we turned to the O-glyc b(5)
construct. The first step in O-glycosylation is attachment
of an N-acetylgalactosamine (GalNac) residue to Thr or
Ser residues, and the enzymes responsible for this reac-
tion, the GalNac transferases, have been localized to the
 
cis
 
-Golgi as well as to more distal cisternae (Röttger et al.,
1998).
We first compared the electrophoretic mobility of in
vivo synthesized O-glyc b(5) with that of the in vitro gen-
erated primary translation product. As shown in Fig. 7 A,
the product expressed in transfected cells (Fig. 7 A, lane 1)
comigrated with the product synthesized in vitro in the ab-
sence (Fig. 7 A, lane 2) or presence (Fig. 7 A, lane 3) of
membranes. However, if cells were incubated with BFA,
O-glyc b(5) was shifted to a higher apparent 
 
M
 
r
 
 (compare
Fig. 7 B, lanes 3 and 4, or Fig. 7 B, lanes 5 and 6), indicat-
ing that at least one of the potential O-glycosylation sites
could be used if the protein came into contact with the rel-
evant enzymes. To see whether in the absence of BFA the
initial steps of O-glycosylation were also taking place but
were not resulting in reduced electrophoretic mobility of
O-glyc b(5), we carried out metabolic labeling experi-
ments with 
 
3
 
H-labeled sugars. As shown in Fig. 7 B, incu-
bation with [
 
3
 
H]GlcNH
 
2
 
, which serves as precursor both to
UDP-GlcNac and to UDP-GalNac, resulted in labeling of
O-glyc b(5) both in the absence (Fig. 7 B, lane 3) and the
presence (Fig. 7 B, lane 4) of BFA. The labeling was spe-
cific, because under the same conditions, wt b(5) was not
labeled (Fig. 7 B, lanes 1 and 2), although it was efficiently
expressed, as shown by the Western blot in the lower part
of Fig. 7 B.
The second sugar to be added on O-linked oligosaccha-
rides is galactose. With [
 
3
 
H]galactose as radioactive pre-
cursor, O-glyc b(5) became labeled in the presence of
BFA (Fig. 7 B, lane 6), and a weak signal was obtained
also in the absence of the drug (Fig. 7 B, lane 5). Thus, at
steady-state, a small portion of the O-glyc mutant has also
undergone the second step of O-glycosylation.
To investigate how rapidly glycosylation of O-glyc b(5)
occurs after its synthesis, we followed the time course of
incorporation of 
 
3
 
H-labeled sugar after blocking protein
synthesis with CHX (Fig. 8). Cells were first incubated for
3 h with [
 
3H]GlcNH2 to allow for equilibration between
UDP-[3H]GlcNac and UDP-[3H]GalNac. Incubation was
then continued in the presence or absence of CHX. To
control for the efficacy of the block in protein synthesis, a
separate set of dishes of transfected cells was incubated in
parallel with [35S]Met/Cys in the presence or absence of
CHX, and O-glyc b(5) immunoprecipitates were then ana-
lyzed (Fig. 8 B). CHX efficiently blocked the synthesis of
O-glyc b(5) (Fig. 8 B; compare lanes 2 and 4 with lanes 1
and 3). However, as shown in Fig. 8 A and on the graph on
the right side of Fig. 8 C (obtained by normalizing the
amount of immunoprecipitated 3H-labeled O-glyc b[5] to
the amount of O-glyc b[5] expressed, as determined by
Western blotting), the block in protein synthesis had no ef-
fect at all on the rate of sugar incorporation, which contin-
ued at a linear rate for 4 h after addition of the drug. This
result stands in sharp contrast to the strong inhibitory ef-
fect of CHX on the incorporation of labeled sugar into to-
tal cellular proteins (graph on the left side of Fig. 8 C).
Thus, there is a large pool of unglycosylated O-glyc b(5)
molecules that acquire O-linked sugar at a low rate. It
should be mentioned that incubation with CHX for 4 h did
not cause an appreciable decrease in the total amount of
O-glyc b(5) or in the accumulation of the labeled species
(compare Fig. 8 A, lanes 4 and 5) in this and other experi-
ments, indicating that under these conditions O-glyc b(5)
is stable. The variations in the amounts sometimes de-
tected in Western blots (e.g., Fig. 8 A, lanes 3–5 vs. Fig. 8
A, lanes 1 and 2) are presumably due to differences in
transfection efficiencies in the different dishes.
The bulk of the available evidence indicates that the
Figure 6. The N-linked oligosaccharide of N-glyc b(5) retains
Endo H sensitivity and Endo D resistance. (A) CV1 cells trans-
fected with N-glyc b(5) cDNA were labeled for 2 h with [35S]Met/
Cys, then chased for a further 6 h. One set of cells was exposed to
BFA (10 mg/ml) 30 min before starting the labeling, and was kept
with the drug for the entire pulse and chase period (lanes 5 and
6). At the end of the pulse (lanes 1 and 2) or after the chase
(lanes 2–6), cells were harvested, lysed, and subjected to immu-
noprecipitation with antiopsin mAbs. Aliquots containing the
same amounts of incorporated radioactive amino acid were used
for each immunoprecipitation. One half of each immunoprecipi-
tate was treated with Endo H (lanes 2, 4, and 6), whereas the
other half was left untreated (lanes 1, 3, and 5). (B) CHO 15B
cells, transfected with N-glyc b(5) cDNA, were labeled for 2 h
and chased for 6 h with [35S]Met/Cys. One set of cells (lanes 3 and
4) was exposed to BFA as in A. At the end of the chase period,
cells were harvested, lysed, and subjected to immunoprecipita-
tion as in A. One half of the immunoprecipitates was treated with
Endo D (lanes 2 and 4), whereas the other half was left untreated
(lanes 1 and 3). The figure shows the result of the SDS-PAGE
fluorography analysis of the Endo H– or Endo D–treated and un-
treated immunoprecipitates. The position of the 21-kD molecular
mass marker is shown at the left of each panel. The vertical arrow
in lane 2 of B indicates the position of the unglycosylated N-glyc
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process of O-glycosylation occurs in the Golgi complex
(Roth et al., 1994; Schweizer et al., 1994; Röttger et al.,
1998). However, under some conditions, especially in in-
fected cells, the initial steps may take place in a compart-
ment upstream of the Golgi (discussed in Röttger et al.,
1998). Moreover, recent evidence indicates that Golgi-res-
ident enzymes slowly recycle through the ER (Cole et al.,
1998; Storrie et al., 1998; Girod et al., 1999). To investigate
whether O-glyc b(5) must leave the ER to become glyco-
sylated, we treated cells with the phosphatase inhibitor
OKA, a drug which blocks exit from the ER (Davidson et al.,
1992; Pryde et al., 1998). Transfected cells were exposed to
[3H]GlcNH2 for 3 h and then incubated further for another
hour in the presence or absence of OKA. At this time cells
were collected for biochemical analysis or analyzed by im-
munofluorescence. As shown in Fig. 9 C, the intracellular
localization of O-glyc b(5) (Fig. 9 C, panels a and d) and of
a Golgi marker (giantin; Fig. 9 C, panels c and f) were un-
affected by OKA. In contrast, ERGIC 53 was dispersed
from the Golgi area to more peripherally located struc-
tures (compare Fig. 9 C, panels e and b). These results are
consistent with OKA’s inhibition of ER-to-Golgi trans-
port. At slightly later times of incubation, ERGIC 53 ap-
peared uniformly distributed within the ER, but the cells
began to suffer and to retract from the substrate (data not
shown). Analysis by immunoprecipitation and Western
blotting (Fig. 9, A and B) showed a 3.2-fold increase in la-
beling of O-glyc b(5) between 3 and 4 h in the absence of
OKA, and an z50% inhibition of this increase by OKA.
This is a fairly strong effect if one considers that OKA
does not exert its full inhibitory activity immediately after
addition (Davidson et al., 1992).
To exclude the possibility that OKA was decreasing
O-glyc b(5) glycosylation through a direct or indirect inhibi-
tion of glycosyl transferases and not by a transport block,
we analyzed its effect in the presence of BFA. As can be
seen in Fig. 9 A, the effect of OKA was reversed in the
presence of BFA (Western blot; Fig. 9 A, lanes 3 and 5).
During a 1-h period of incubation with BFA, 41.7 6 1.7%
and 37.6 6 1.6% (average 6 half-range of two experi-
ments) of O-glyc b(5) was converted to the slower migrat-
ing, fully processed form in the absence and presence of
OKA, respectively.
Another important piece of information in Fig. 9 can be
obtained by examining the ratio of specific radioactivity
(immunoprecipitate/Western) of O-glyc b(5) attained in
the absence and presence of BFA (Fig. 9 A, lanes 2 and 3).
By scanning a lower exposure of fluorographs in which the
bands labeled in the presence of BFA had not saturated
the film (data not shown), we found that the specific radio-
activity attained in 1 h by O-glyc b(5) in the absence of
drugs was z7% that attained by the lower Mr polypeptide
of the doublet generated in the presence of BFA. Since the
higher Mr  band presumably contains additional labeled
sugar, it could not be compared with the more rapidly mi-
grating polypeptide. If one assumes that the lower Mr
band of Fig. 9 A, lane 3 is 100% glycosylated, this would
indicate a half-time for glycosylation of O-glyc b(5) (in the
absence of BFA) of z10 h, in agreement with the slow ac-
quisition of sugar after the blockade of protein synthesis
demonstrated in Fig. 8. This half-time may be an underes-
timate, since a fraction of the low Mr  polypeptide mole-
cules of Fig. 9 A, lane 3 may be unglycosylated.
The results of Fig. 9 suggest that O-glyc b(5) must leave
the ER to become glycosylated. But does O-glyc b(5) re-
turn to its compartment of origin once it has exited? This
question was investigated both by immunofluorescence
and by cell fractionation (Fig. 10). We carried out immuno-
Figure 7. O-glyc b(5) becomes glycosylated in
vivo. (A) Comparison of SDS-PAGE mobility of
in vivo and in vitro synthesized O-glyc b(5). CV1
cells transfected with O-glyc b(5) cDNA were la-
beled for 2 h with [35S]Met/Cys, harvested, and
subjected to immunoprecipitation with anti-b(5)
Abs (lane 1). Alternatively, synthetic RNA cod-
ing for O-glyc b(5) was translated in vitro either
in the absence (lane 2) or in the presence (lane 3)
of dog pancreas microsomes. SDS-PAGE fol-
lowed by fluorography fails to reveal a difference
between the apparent Mr  of the protein synthe-
sized in vivo and that of the primary translation
product produced in vitro. (B) Metabolic label-
ing of O-glyc b(5) with 3H-labeled sugars. CV1
cells, transfected with wt b(5) (lanes 1 and 2) or
with O-glyc b(5) (lanes 3–6) cDNA, were incu-
bated for 7 h with [3H]GlcNH2 (lanes 1–4) or
[3H]Gal (lanes 5 and 6). For each labeling condi-
tion, one set of cells (lanes 2, 4, and 6) received
10 mg/ml of BFA 30 min before exposure to the
labeled sugar, and the drug was maintained in
the medium during the entire subsequent incuba-
tion. At the end of the incubation, cells were har-
vested, lysed, and aliquots containing the same
amounts of incorporated radioactive sugar were
subjected to immunoprecipitation with anti-b(5) Abs. Immunoprecipitates were analyzed by SDS-PAGE fluorography (upper panel).
One fourth of the amounts used for immunoprecipitation were analyzed by Western blotting with anti-b(5) Abs (lower panel). The line
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fluorescence analysis of transfected cells after long expo-
sures (4 and 8 h) to CHX. From the data of Fig. 8, O-glyc
b(5) acquires sugar linearly for up to 4 h in the presence of
CHX, and on the basis of the estimate of 10 h for the half-
time of O-glycosylation (Fig. 9), z25% of O-glyc b(5)
molecules should have acquired sugar at this time. A con-
centration of these glycosylated molecules in the glycosy-
lation compartment (cis-Golgi) should have been detect-
able by immunofluorescence. However, as shown in Fig.
10 A, the tagged protein retained a similar distribution to
that of the ER protein ribophorin I at 4 h of incubation
(Fig. 10 A, panels a–c), and did not colocalize with the
Golgi marker giantin even after 8 h of incubation with
CHX (Fig. 10 A, panels d–f). Fig. 10 A, panels a–c also
show an example of the b(5)-rich structures that began to
appear in some of the cells in this experiment (the arrow-
heads indicate two such structures). As shown in Fig. 10 A,
panels b and c, ribophorin I also localized to these struc-
tures, suggesting that they represent proliferations of the
ER. The frequency of these structures was, in any case, the
same in cells incubated with or without CHX (data not
shown).
The subcellular localization of glycosylated O-glyc b(5)
was also analyzed by Optiprep density gradient centrifu-
gation of a PNS from cells metabolically labeled with
[3H]GlcNH2 (Fig. 10 B). Under the conditions used, the
ER marker NADPH-cyt P450 reductase showed a sharp
peak of activity centered at fraction 6, corresponding to a
density of 1.1 (Fig. 10 B, panel b), whereas GS28, a marker
for the cis-Golgi (Subramaniam et al., 1995), was broadly
distributed throughout the gradient and present also in the
bottom fractions immediately adjacent to the load zone
(Fig. 10 B, panel d). Total O-glyc b(5), detected by West-
ern blot (Fig. 10 B, panel a), peaked at a slightly lower
density (fraction 5) than the reductase. A portion of
O-glyc b(5) floated to the top of the gradient. This mate-
rial probably corresponds to membrane fragments of low
density, which we have not characterized further. Finally,
3H-labeled O-glyc b(5), detected by immunoprecipitation
(Fig. 10 B, panel c), had a distribution similar to that of to-
tal O-glyc b(5), and was depleted from the region of the
gradient more enriched in GS28 (fractions 7–9). These re-
sults suggest that unglycosylated and glycosylated O-glyc
b(5) molecules coexist within the same compartment, and
also that both may be enriched in smooth subdomains of
the ER.
Discussion
Both retention and retrieval mechanisms are thought to be
involved in keeping ER resident proteins from escaping
down the secretory pathway. The identification of specific
retrieval sequences has spurred a large amount of work
that has resulted in a significant increase in our under-
standing of the retrograde pathway (Pelham and Munro,
1993; Cosson and Letourneur, 1994; Teasdale and Jack-
son, 1996; Cosson et al., 1998). However, most of this work
has been carried out on chimeras, consisting of a retrieval
signal grafted onto a protein normally destined for export
from the ER, and there is still not much information on
the relative roles of retention and retrieval in determining
the residence of bona fide ER proteins. A few mammalian
ER membrane proteins have been studied by analyzing
the processing of N-linked glycans attached to endogenous
or engineered consensus sites. Due the failure of these
proteins to acquire Endo H resistance, it has been con-
Figure 8. Time course of posttranslational addition of 3H-labeled
sugar to O-glyc b(5). (A) Metabolic labeling with [3H]GlcNH2.
Cells transfected with O-glyc b(5) were incubated for 3 h with
[3H]GlcNH2  to allow for equilibration between UDP-
[3H]GlcNAc and UDP-[3H]GalNAc. Cells from one dish were
harvested at this point (lane 1), whereas the others were incu-
bated for a further 1 (lanes 2 and 3) or 4 (lanes 4 and 5) h in the
presence or absence of 15 mg/ml CHX as indicated. For each time
point, cell lysates were prepared, and equal amounts of protein
were used for immunoprecipitation with anti-b(5) Abs (upper
panel). A proportional amount of each lysate (one fifth of the
amount used for immunoprecipitation) was analyzed by Western
blotting (lower panel). (B) Block of O-glyc b(5) synthesis by
CHX. Cells transfected with O-glyc b(5) were incubated in paral-
lel with those in A, but without added [3H]GlcNH2. After 3 h,
[35S]Met/Cys was added and incubation was continued in the
presence or absence of 15 mg/ml CHX, as indicated. At the indi-
cated times, cell lysates were prepared and equal amounts of pro-
tein were used for immunoprecipitation, as in A. (C) Graphical
representation of the results of A compared with the incorpora-
tion of 3H-labeled sugar into total protein. The graph on the right
shows the ratios of band intensities of fluorographs (metaboli-
cally labeled O-glyc b[5]) to those of the Western blots (total
O-glyc b[5]). Shown are the means from three sets of dishes 6
SEM. The value for the ratio at 3 h (time of addition of CHX) has
been normalized to 1. The graph on the left represents total
TCA-precipitable 3H-labeled sugar normalized to total protein
content. Squares, no CHX; triangles, CHX.Pedrazzini et al. Intracellular Sorting of Cytochrome b(5) 909
cluded that they reside in the ER by a true retention
mechanism (Ahn et al., 1993; Masaki et al., 1996; Duvet
et al., 1998; Honsho et al., 1998). However, since Endo H
resistance is acquired in the medial Golgi, these studies
could not exclude that retrieval from an earlier Golgi com-
partment was occurring. In this study, we have addressed
this problem by attaching short sequences, containing ei-
ther N- or O-glycosylation sites, to the COOH terminus of
b(5), a TA protein of the ER. We show that in the O-glyc
mutant at least one glycosylation site is used, indicating
that the tagged protein comes in contact with cis-Golgi en-
zymes, an event which could not be detected by analysis of
the oligosaccharide of the N-glyc–tagged version. The
methodology used here should also be useful for the study
of the trafficking of other ER membrane proteins, particu-
larly of those lacking lumenal domains with endogenous
glycosylation sites.
Posttranslational Translocation of the COOH Terminus 
of b(5) across the ER Membrane
Before undertaking an investigation of the intracellular
Figure 9. OKA inhibits sugar
acquisition by O-glyc b(5).
(A) CV1 cells transfected
with O-glyc b(5) were incu-
bated with [3H]GlcNH2 for
3 h to allow for equilibration
between UDP-[3H]GlcNAc
and UDP-[3H]GalNAc. At
this time, one set of cells was
harvested (lane 1), whereas
the others were incubated for
a further hour in the presence
(lanes 4 and 5) or absence
(lanes 2 and 3) of 1 mM OKA
with or without 10 mg/ml
BFA, as indicated. After
clearing of lysates, equal
amounts of protein were sub-
jected to immunoprecipita-
tion with anti-b(5) Abs (up-
per panel). A proportional
amount of each lysate (one
fifth of the amount used for
immunoprecipitation) was
analyzed by Western blotting
(lower panel). (B) Graphical
representation of the results
of two experiments like the
one in A. Two separate sets
of dishes were labeled as de-
scribed for A. The ratio of the
intensities of the O-glyc b(5)
bands detected by fluorogra-
phy to that of the bands in
corresponding samples de-
tected by Western blotting is
plotted. Shown are the means
values 6 half-range. (C) Im-
munofluorescence analysis of
cells treated or not treated
with 1 mM OKA. After 1 h
with (C, panels d–f) or with-
out (C, panels a–c) OKA,
cells were fixed. Separate
coverslips were analyzed for
b(5) (C, panels a and d),
ERGIC 53 (C, panels b and
e), and giantin (C, panels c
and f). Note the redistribu-
tion of ERGIC 53 induced by
OKA, whereas O-glyc b(5)
and giantin appear unaffected
by the drug. Bar, 20 mm.The Journal of Cell Biology, Volume 148, 2000 910
sorting of b(5), we judged it necessary to define the topol-
ogy of its membrane-anchoring domain. Although this
problem has been the object of numerous investigations,
there were still conflicting views as to whether b(5)’s hy-
drophobic domain adopts a transmembrane disposition
with the extreme COOH-terminal residues in the lumen of
the ER, or whether it has a hairpin topology with the
COOH terminus looping back into the cytosol (Dailey and
Figure 10. Intracellular dis-
tribution of O-glyc b(5). (A)
O-glyc b(5) remains in the
ER after prolonged incuba-
tion with CHX. CV1 cells
transfected with O-glyc b(5)
were incubated under the
same conditions as in the ex-
periments of Figs. 8 and 9,
but without the labeled pre-
cursor and in the presence of
20 mg/ml of CHX for 4 (A,
panels a–c) or 8 (A, panels
d–f) h. Fixed cells were dou-
bly labeled with anti-b(5)
and anti–ribophorin I Abs
(A, panels a–c), or with anti-
b(5) and antigiantin Abs (A,
panels d–f). A single confo-
cal section is shown for the 4-
and 8-h incubation. Images
of the same field were ac-
quired separately with the
Texas red (A, panels a and d)
and the fluorescein (A, pan-
els b and e) filters. The corre-
sponding merged images are
shown in A, panels c and f
(O-glyc b[5] in red, marker
protein in green). Note the
absence of colocalization of
O-glyc b(5) with giantin and
its similar distribution to ri-
bophorin I. The arrowheads
in A, panels a–c indicate
structures in which O-glyc
b(5) accumulates at long
times after transfection, and
which are also positive for ri-
bophorin I. Bar: (panels a–c)
10 mm; (panels d–f) 20 mm.
(B) Optiprep density gradi-
ent analysis of CV1 cells
transfected with O-glyc b(5)
and metabolically labeled
with [3H]GlcNH2. Cells were
metabolically labeled with
[3H]GlcNH2 for 6 h, then re-
turned to DME for 4 h, be-
fore collection, homogeniza-
tion, and preparation of a
PNS, which was loaded un-
der an 8–22% Optiprep gra-
dient (see Materials and
Methods). After centrifuga-
tion, fractions were collected
and analyzed for O-glyc b(5)
by Western blotting (B,
panel a), NADPH-cyt c re-
ductase enzyme activity (B,
panel b), 3H-labeled O-glyc
b(5) by immunoprecipitation followed by SDS-PAGE fluorography (B, panel c), and GS28 by Western blotting (B, panel d). The thick
line positioned at the right of each graph covers the fractions containing the load zone of the gradient.Pedrazzini et al. Intracellular Sorting of Cytochrome b(5) 911
Strittmatter, 1981; Arinc et al., 1987; Ozols, 1989; Chester
et al., 1992; Borgese et al., 1993; Vergères et al., 1995;
Kuroda et al., 1996). However, strong evidence for a trans-
membrane topology for b(5) was provided recently by the
finding that a tagged version bearing an N-glycosylation
consensus sequence at the COOH terminus acquired
N-linked carbohydrate (Honsho et al., 1998). Although
this study proved that the COOH terminus of this con-
struct is translocated into the ER lumen in vivo, it did not
investigate the mechanism of this translocation, leaving
open the possibility that the addition of polar residues at
the COOH terminus could cause a translocation that does
not occur with the wt, untagged polypeptide. For instance,
the additional 15–20 COOH-terminal amino acids could
lead to a partial exposure of residues of the hydrophobic
domain before termination of translation, resulting in the
binding of the signal recognition particle and in a translo-
con-dependent translocation. For this reason, and since
the wt protein is synthesized on free polysomes and inserts
into membranes after release from the ribosomes, it was
important to establish that the translocation of the COOH
terminus of COOH-terminally tagged b(5) could occur
posttranslationally in the absence of ribosomes. Our re-
sults with the N-glyc b(5) mutant show that this is indeed
the case, a strong indication that in the wt protein the
seven polar COOH-terminal residues are also in the lu-
men of the ER. In agreement with this conclusion, in im-
munofluorescence experiments we found that the COOH-
terminal polar peptide is not accessible to Abs unless the
ER membrane is permeabilized with Triton X-100. Taken
together these results justify the use of COOH-terminally
tagged versions of b(5) to study its intracellular trafficking.
Although the hydrophobic domain of b(5), in its ability
to translocate downstream residues across the ER mem-
brane, superficially resembles the signal anchor sequences
of classical type II proteins, the mechanism by which it
functions is quite different, since it operates on the re-
leased polypeptide in the absence of ribosomes. An in
vitro posttranslational translocation similar to that of the
b(5) COOH terminus has been shown also for synaptobre-
vin I (Kutay et al., 1995), a synaptic vesicle soluble N-eth-
ylmaleimide–sensitive factor attachment protein receptor
with a considerably longer hydrophobic domain than b(5).
The insertion of synaptobrevin appeared to require pro-
teins different from those of the classical Sec61-based
translocation apparatus. It is likely that b(5) and synapto-
brevin, as well as all other TA proteins, translocate their
COOH terminus with the same mechanism, which cer-
tainly deserves further investigation.
Retention or Retrieval?
To investigate whether b(5) is retrieved from the IC or
from the cis-Golgi, we first compared its distribution by
immunofluorescence with that of the IC marker, ERGIC
53, after incubation either under normal conditions or at
158C, a temperature which interferes with trafficking be-
tween the ER and the Golgi, and which has been shown in
some cases to cause accumulation of recycling ER proteins
in the IC (Jackson et al., 1993). However, for b(5), this ap-
proach did not yield any evidence in favor of its movement
out of the ER. Proteins that recycle slowly may not be cap-
tured in the IC by incubation at low temperature (Jackson
et al., 1993), presumably because entry as well as exit from
the IC may be slowed. Therefore, we turned to the use of
lumenally tagged versions of b(5) (N-glyc and O-glyc
b[5]), with the aim of using the attached oligosaccharide
chains as reporters for the intracellular compartments vis-
ited by b(5). These tagged constructs were inserted into
membranes with the correct topology, and had an intracel-
lular distribution indistinguishable from that of transiently
expressed wt b(5). During a 6-h chase, N-glyc b(5) did not
acquire Endo H resistance, and also remained nearly com-
pletely Endo D–resistant, suggesting that it was not reach-
ing the medial Golgi. However, when we turned to a more
stringent assay based on the incorporation of sugar into
the O-glyc mutant, we found that at least one O-glycosyla-
tion site was used, indicating that the protein was coming
into contact with a GalNac transferase, enzymes which are
localized to the Golgi complex (Röttger et al., 1998). We
believe that the acquisition of carbohydrate by O-glyc b(5)
is reporting on a recycling event through the cis-Golgi, for
the reasons detailed below.
Processing of a glycoprotein by Golgi enzymes has nor-
mally been taken as evidence for its passage though the
Golgi complex. However, recent evidence showing that
Golgi enzymes recycle slowly through the ER (Cole et al.,
1998; Storrie et al., 1998; Girod et al., 1999) makes it more
difficult to interpret the significance of Golgi modifica-
tions on ER proteins. Nonetheless, since ER proteins gen-
erally do not carry Golgi modifications, it seems that these
recycling Golgi enzymes are not active within the ER.
Therefore, it is probable that O-glyc b(5) acquired its
sugar after leaving the ER, and this idea is supported by
the finding that glycosylation of O-glyc b(5) could be in-
hibited by the phosphatase inhibitor OKA, which blocks
transport out of the ER (Davidson et al., 1992; Pryde et al.,
1998). If O-glyc b(5) had been modified within the ER by
recycling Golgi enzymes, OKA might actually have in-
creased the processing of O-glyc b(5) by the trapped gly-
cosyl transferases. Another explanation for our data is that
the tagged protein, after exiting the ER and becoming gly-
cosylated, did not return to its compartment of origin. This
interpretation is unlikely, since no redistribution of O-glyc
b(5) from the ER to another compartment could be ob-
served after a chase with CHX under conditions in which
the proportion of glycosylated O-glyc b(5) molecules
was increasing at a linear rate. Moreover, [3H]GlcNH2-
labeled and total O-glyc b(5) had similar distributions on
an Optiprep density gradient, suggesting that they coexist
in the same intracellular compartment.
Does the behavior of overexpressed O-glyc b(5) reflect
that of endogenous b(5) in mammalian cells? It is possible
that overexpression causes leakage from the ER of the
tagged b(5) or that the tag itself alters the behavior of b(5).
Although we cannot exclude either of these possibilities,
the important finding here is that b(5) appears to have the
capacity to be captured and returned to the ER from a
downstream compartment, even though the extent of exit
from the ER for the endogenous molecule and the overex-
pressed tagged mutant may be different. The rate of acqui-
sition of carbohydrate by O-glyc b(5) was in any case quite
slow: by comparing the extent of labeling of the tagged
protein in the presence or absence of BFA, we estimated a
half-time for acquisition of O-linked GalNac of z10 h.
This slow rate of glycosylation, as well as the lack of colo-The Journal of Cell Biology, Volume 148, 2000 912
calization of wt and tagged versions of b(5) with markers
for the IC, suggest that b(5) tends to be excluded from
budding transport vesicles, and that retrieval from a down-
stream compartment represents a salvage mechanism for
those molecules that occasionally leak out of the ER. In
other words, it would appear that both retention and re-
trieval are operating together to keep b(5) in the ER. We
do not know at present whether retention is based simply
on the lack of a positive export signal and/or the presence
of a positive retention signal or feature in b(5). Formation
of oligomeric complexes has been suggested to result in re-
tention of some ER proteins (Yu et al., 1989). However,
this mechanism would not seem to be responsible for b(5)
retention. Indeed, our sucrose gradient analysis did not
reveal the presence of b(5) oligomers under conditions
in which high-Mr complexes containing ribophorin I
were preserved. Consistent with this result, preliminary ex-
periments carried out with the fluorescence recovery af-
ter photobleaching technique suggest that green fluores-
cent protein–b(5) chimeras diffuse rapidly across the ER
(Snapp, E., and J. Lippincott-Schwartz, personal commu-
nication).
Our previous work demonstrated that a short hydropho-
bic domain is required to keep b(5) in the ER; lengthening
of the TMD results in escape of b(5) from the ER and its
arrival at the plasma membrane (Pedrazzini et al., 1996).
The extension of this finding by other laboratories to other
TA proteins and reporter constructs (Rayner and Pelham,
1997; Yang et al., 1997; Honsho et al., 1998) suggests that
TMD-dependent sorting may be a general phenomenon
for TA proteins and may occur by a common mechanism.
The results of the present study, which suggest that both
retention and retrieval mechanisms are operating to keep
b(5) in the ER, raise the question as to whether the short
TMD is required for retention, retrieval, or for both these
phenomena. If the TMD is involved in retrieval, a candi-
date recycling receptor involved in this process is rer1p, a
protein demonstrated to be required for ER residence of a
number of membrane polypeptides in yeast via recogni-
tion of their TMDs (Sato et al., 1996, 1997). This receptor,
which also has been cloned from mammalian cells (Fulle-
krug et al., 1997), appears to prefer short and somewhat
hydrophilic TMDs (Letourneur and Cosson, 1998). On the
other hand, retrieval of TA proteins may occur by a com-
pletely different mechanism, since Ufe1p, a TA target sol-
uble  N-ethylmaleimide–sensitive factor attachment pro-
tein receptor of the ER, does not change its localization in
rer1p-deficient yeast cells (Rayner and Pelham, 1997).
Further work with tagged versions of TA proteins like the
ones described in this study should help to define at the
molecular level the sorting mechanisms of this class of pro-
teins.
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